http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 10 May 2024 14:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Eiger+BioPharmaceuticals+++++++++++++++Filed+by%3A+AMERIPRISE+FINANCIAL+INC/23208246.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Eiger+BioPharmaceuticals+++++++++++++++Filed+by%3A+AMERIPRISE+FINANCIAL+INC/23208246.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Eiger+BioPharmaceuticals+++++++++++++++Filed+by%3A+AMERIPRISE+FINANCIAL+INC/23208246.html Fri, 10 May 2024 14:15:00 -0400 EIGR O.13746763 http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Eiger+BioPharmaceuticals+++++++++++++++Filed+by%3A+AMERIPRISE+FINANCIAL+INC/23208246.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Eiger+BioPharmaceuticals+++++++++++++++Filed+by%3A+AMERIPRISE+FINANCIAL+INC/23208246.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Eiger+BioPharmaceuticals+++++++++++++++Filed+by%3A+AMERIPRISE+FINANCIAL+INC/23208246.html Fri, 10 May 2024 14:15:00 -0400 EIGR O.13746763 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eiger+BioPharmaceuticals++For%3A+May+03/23196038.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eiger+BioPharmaceuticals++For%3A+May+03/23196038.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eiger+BioPharmaceuticals++For%3A+May+03/23196038.html Wed, 08 May 2024 17:01:00 -0400 EIGR O.13746763 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eiger+BioPharmaceuticals++For%3A+May+03/23196038.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eiger+BioPharmaceuticals++For%3A+May+03/23196038.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eiger+BioPharmaceuticals++For%3A+May+03/23196038.html Wed, 08 May 2024 17:01:00 -0400 EIGR O.13746763 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/Press+Releases/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344 http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html for the full story. http://www.streetinsider.com/PRNewswire/Sentynl+Therapeutics+Announces+Global+Acquisition+of+Zokinvy%C2%AE+%28Lonafarnib%29+for+Treatment+of+Hutchinson-Gilford+Progeria+Syndrome+from+Eiger+BioPharmaceuticals/23172792.html Fri, 03 May 2024 17:00:00 -0400 A.06822034 A.12461752 A.19655944 A.60012004 EIGR EIGRQ EIGRQ O.00048985 O.03307993 O.13746763 O.20026344